Ikarian Capital »

Biohaven shares owned by Ikarian Capital

Quarter-by-quarter ownership of Biohaven shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $12M 796k 15.01
2025-06-30 $4.2M 300k 14.11

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Biohaven

Ikarian Capital
Oracle Investment Management
Simplex Trading
Group One Trading
IMC-Chicago

View all funds holding Biohaven